Portal de Periódicos da CAPES

The Growing Paradigm of Preventing Disease: Vaccines To Prevent Herpes Zoster and Pertussis in Adults

2005; American College of Physicians; Volume: 143; Issue: 7 Linguagem: Inglês

10.7326/0003-4819-143-7-200510040-00013

1539-3704

Gregory A. Poland,

Virology and Viral Diseases

Editorials4 October 2005The Growing Paradigm of Preventing Disease: Vaccines To Prevent Herpes Zoster and Pertussis in AdultsGregory A. Poland, MDGregory A. Poland, MDFrom Mayo Clinic and Foundation, Rochester, MN 55905.Search for more papers by this authorAuthor, Article, and Disclosure Informationhttps://doi.org/10.7326/0003-4819-143-7-200510040-00013 SectionsAboutFull TextPDF ToolsAdd to favoritesDownload CitationsTrack CitationsPermissions ShareFacebookTwitterLinkedInRedditEmail Two recent studies have shown the safety and efficacy of vaccines designed to prevent infectious diseases occurring among adults—herpes zoster (shingles) and pertussis (1, 2). The availability of these vaccines expands the growing paradigm of active disease prevention in adults. An acellular pertussis vaccine is now approved by the U.S. Food and Drug Administration (FDA) and available for use in adults (Adacel, Sanofi Pasteur, Swiftwater, Pennsylvania); the zoster vaccine (Zostavax, Merck Research Laboratories, New York, New York) is pending licensure application.A Vaccine To Prevent Herpes Zoster in AdultsIt is estimated that approximately 1 million cases of herpes zoster ...References1. Oxman MN, Levin MJ, Johnson GR, Schmader KE, Straus SE, Gelb LD, et al. A vaccine to prevent herpes zoster and postherpetic neuralgia in older adults. N Engl J Med. 2005;352:2271-84. [PMID: 15930418] CrossrefMedlineGoogle Scholar2. Pichichero ME, Rennels MB, Edwards KM, Blatter MM, Marshall GS, Bologa M, et al. Combined tetanus, diphtheria, and 5-component pertussis vaccine for use in adolescents and adults. JAMA. 2005;293:3003-11. [PMID: 15933223] CrossrefMedlineGoogle Scholar3. Ragozzino MW, Melton LJ, Kurland LT, Chu CP, Perry HO. Population-based study of herpes zoster and its sequelae. Medicine (Baltimore). 1982;61:310-6. [PMID: 6981045] CrossrefMedlineGoogle Scholar4. Miller AE. Selective decline in cellular immune response to varicella-zoster in the elderly. Neurology. 1980;30:582-7. [PMID: 6247671] CrossrefMedlineGoogle Scholar5. Levin MJ, Hayward AR. The varicella vaccine. Prevention of herpes zoster. Infect Dis Clin North Am. 1996;10:657-75. [PMID: 8856358] CrossrefMedlineGoogle Scholar6. Berger R, Luescher D, Just M. Restoration of varicella-zoster virus cell-mediated immune response after varicella booster vaccination. Postgrad Med J. 1985 Suppl 143-5. [PMID: 3014472] MedlineGoogle Scholar7. Levin MJ, Murray M, Zerbe GO, White CJ, Hayward AR. Immune responses of elderly persons 4 years after receiving a live attenuated varicella vaccine. J Infect Dis. 1994;170:522-6. [PMID: 8077709] CrossrefMedlineGoogle Scholar8. Levin MJ, Murray M, Rotbart HA, Zerbe GO, White CJ, Hayward AR. Immune response of elderly individuals to a live attenuated varicella vaccine. J Infect Dis. 1992;166:253-9. [PMID: 1321859] CrossrefMedlineGoogle Scholar9. De Serres G, Shadmani R, Duval B, Boulianne N, Déry P, Douville Fradet M, et al. Morbidity of pertussis in adolescents and adults. J Infect Dis. 2000;182:174-9. [PMID: 10882595] CrossrefMedlineGoogle Scholar10. Yih WK, Lett SM, des Vignes FN, Garrison KM, Sipe PL, Marchant CD. The increasing incidence of pertussis in Massachusetts adolescents and adults, 1989-1998. J Infect Dis. 2000;182:1409-16. [PMID: 11023464] CrossrefMedlineGoogle Scholar11. Halperin SA, Marrie TJ. Pertussis encephalopathy in an adult: case report and review. Rev Infect Dis. 1991;13:1043-7. [PMID: 1775835] CrossrefMedlineGoogle Scholar12. Edwards KM. Pertussis epidemiology and transmission. Advanced Studies in Medicine. 2005:S440-S443. Google Scholar13. Nennig ME, Shinefield HR, Edwards KM, Black SB, Fireman BH. Prevalence and incidence of adult pertussis in an urban population. JAMA. 1996;275:1672-4. [PMID: 8637142] CrossrefMedlineGoogle Scholar14. Wright SW, Edwards KM, Decker MD, Zeldin MH. Pertussis infection in adults with persistent cough. JAMA. 1995;273:1044-6. [PMID: 7897789] CrossrefMedlineGoogle Scholar15. Rosenthal S, Strebel P, Cassiday P, Sanden G, Brusuelas K, Wharton M. Pertussis infection among adults during the 1993 outbreak in Chicago. J Infect Dis. 1995;171:1650-2. [PMID: 7769311] CrossrefMedlineGoogle Scholar16. Senzilet LD, Halperin SA, Spika JS, Alagaratnam M, Morris A, Smith B, et al. Pertussis is a frequent cause of prolonged cough illness in adults and adolescents. Clin Infect Dis. 2001;32:1691-7. [PMID: 11360208] CrossrefMedlineGoogle Scholar17. Keitel WA, Edwards KM. Pertussis in adolescents and adults: time to reimmunize? Semin Respir Infect. 1995;10:51-7. [PMID: 7761714] MedlineGoogle Scholar18. Linnemann CC, Ramundo N, Perlstein PH, Minton SD, Englender GS. Use of pertussis vaccine in an epidemic involving hospital staff. Lancet. 1975;2:540-3. [PMID: 51354] CrossrefMedlineGoogle Scholar19. Keitel WA. Cellular and acellular pertussis vaccines in adults. Clin Infect Dis. 1999;28 Suppl 2 S118-23. [PMID: 10447029] CrossrefMedlineGoogle Scholar20. Englund JA, Glezen WP, Barreto L. Controlled study of a new five-component acellular pertussis vaccine in adults and young children. J Infect Dis. 1992;166:1436-41. [PMID: 1431261] CrossrefMedlineGoogle Scholar21. Rothstein EP, Anderson EL, Decker MD, Poland GA, Reisinger KS, Blatter MM, et al. An acellular pertussis vaccine in healthy adults: safety and immunogenicity. Pennridge Pediatric Associates. Vaccine. 1999;17:2999-3006. [PMID: 10462235] CrossrefMedlineGoogle Scholar22. Tran Minh NN, He Q, Edelman K, Putto-Laurila A, Arvilommi H, Viljanen MK, et al. Immune responses to pertussis antigens eight years after booster immunization with acellular vaccines in adults. Vaccine. 2000;18:1971-4. [PMID: 10706957] CrossrefMedlineGoogle Scholar23. Halperin SA, Smith B, Russell M, Hasselback P, Guasparini R, Skowronski D, et al. An adult formulation of a five-component acellular pertussis vaccine combined with diphtheria and tetanus toxoids is safe and immunogenic in adolescents and adults. Vaccine. 2000;18:1312-9. [PMID: 10618527] CrossrefMedlineGoogle Scholar24. Poland GA. Acellular pertussis vaccines: new vaccines for an old disease. Lancet. 1996;347:209-10. [PMID: 8551875] CrossrefMedlineGoogle Scholar25. Poland GA. Still more questions on pertussis vaccines. Lancet. 1997;350:1564-5. [PMID: 9393330] CrossrefMedlineGoogle Scholar26. Gustafsson L, Hallander HO, Olin P, Reizenstein E, Storsaeter J. A controlled trial of a two-component acellular, a five-component acellular, and a whole-cell pertussis vaccine. N Engl J Med. 1996;334:349-55. [PMID: 8538705] CrossrefMedlineGoogle Scholar27. Robbins JB. Pertussis in adults: introduction. Clin Infect Dis. 1999;28 Suppl 2 S91-3. [PMID: 10447024] CrossrefMedlineGoogle Scholar28. Adult immunization initiative. Available at www.acponline.org/aii/index.html. Accessed 6 July 2005. Google Scholar Author, Article, and Disclosure InformationAffiliations: From Mayo Clinic and Foundation, Rochester, MN 55905.Disclosures: Grants received: Merck.Corresponding Author: Gregory A. Poland, MD, Mayo Vaccine Research Group, Mayo Clinic and Foundation, 611C Guggenheim Building, 200 First Street SW, Rochester, MN 55905. PreviousarticleNextarticle Advertisement FiguresReferencesRelatedDetails Metrics Cited byHerpes Zoster in a World Class Triathlete: A Case Report and Evaluation of Training Schedules in Relation to Immune StatusCutaneous Manifestations of HIV DiseaseNational Survey of Primary Care Physicians Regarding Herpes Zoster and the Herpes Zoster VaccineHerpes zoster in 2007: Treatment and prevention 4 October 2005Volume 143, Issue 7Page: 539-541KeywordsAdolescentsChildrenInfantsPertussisRashesSafetyShinglesVaccines ePublished: 4 October 2005 Issue Published: 4 October 2005 Copyright & PermissionsCopyright © 2005 by American College of Physicians. All Rights Reserved.PDF downloadLoading ...